Looking back at 2025

We are aware that we're well into March of 2026 as this is published. But 2025 was quite the year for us, and here's why.

Building a company is rarely without challenge and this past year was no exception. The new US government administration's changed policy regarding scientific research made ProteoFormiX' main resources disappear. On top of that, our CEO was hospitalized with severe post-op complications after undergoing surgery in the fall.

But trying circumstances call for flexibility, and that's exactly what we showcased. A slightly shorter list of conference presentations, but a lot of solid foundations were built for future collaborations and ProteoFormiX' focus expanded to new countries and regions including Canada, Europe, Africa and Australia.

February 13 | Italy

1st Italian MS Imaging Symposium; Milan

[imass.it]

March | USA

a beautiful sunrise in Boston

United States and Canadian Academy of Pathology Annual Meeting; Boston

May | Canada

University Health Network Mass Spectrometry Imaging Symposium; Princess Margaret Cancer Centre; Toronto ON

June 01-05 | USA

Poster presentation by Peter Verhaert & Gilles Frache at ASMS

73rd ASMS; Baltimore MD

[asms.org]

July | Czech Republic & The Pathologist publication

21st Conference of the Metabolomics Society, Prague, Czech Republic

The Pathologist invited us to write a brief article on ProteoFormiX' MSHC approach. You can read it here. Introducing Mass Spectrometry Histochemistry. Pathology’s future lies in unlocking the molecular signals preserved in FFPE tissue.

September 21-26 | Canada

MSACL2025; Montreal QC

[msacl.org]

October | Cyprus

We organized a session at the 2nd Clinical & Translational Omics Symposium in Protaras

[ctosymposium.org] unable to attend due to post-up complications

December 03-06 | Canada

wildlife spotting at Lake Louise

Lake Louise Tandem MS Workshop; Lake Louise AB

[lakelouisemsms.org]

We also instensified our collaboriation with the Laboratory of Applied Mass Spectrometry at University of Leuven Faculty of Medicine, i.e., Prof. Dr. Bart Ghesquière, Dr. Marco Giampà and Dr. Shauni Loopmans.

As always, we are looking forward to uncovering what the rest of 2026 has in store for us as we continue our journey. We can expect some very exciting news from LifeSciences Review this March... Since it might really be too late to wish you a happy new year, we wish you a wonderful start of this week and all the weeks to come.

Photos via ProteoFormiX, Peter Verhaert and Image by katemangostar on Freepi